SCHEMBL4354673

SCHEMBL4354673

CCOC(=O)c1ccc(-c2ccnc(Nc3cc(OC)c(OC)c(OC)c3)n2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 4/20 0.65
EGFR P00533 3/20 0.65
PIK3CG P48736 2/20 0.65
JAK2 O60674 1/20 0.65
PIK3CA P42336 1/20 0.65
PIK3CB P42338 1/20 0.65
PTK2B Q14289 1/20 0.65
ZAP70 P43403 11/20 0.61
PRKD3 O94806 4/20 0.61
PRKCG P05129 4/20 0.61
PRKCB P05771 4/20 0.61
LCK P06239 4/20 0.61
PRKCA P17252 4/20 0.61
PRKCH P24723 4/20 0.61
PRKCI P41743 4/20 0.61
PRKCE Q02156 4/20 0.61
PRKCQ Q04759 4/20 0.61
PRKCZ Q05513 4/20 0.61
PRKCD Q05655 4/20 0.61
PRKD1 Q15139 4/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23897367 0.83 MEN1 (0.57) JAK2IKBKBCHUKMAPK8
SCHEMBL6978697 0.81 CDK2 (0.78) CDK2EGFRPIK3CGJAK2PIK3CA
SCHEMBL2853517 0.81 JAK2 (0.61) CDK2EGFRPIK3CGJAK2PIK3CA
SCHEMBL2861035 0.81 MEN1 (0.55) PIK3CGJAK2PIK3CAPIK3CBIKBKB
SCHEMBL4071652 0.81 MAPK8 (0.67) CDK2PIK3CGJAK2IKBKBCHUK
Dimethylamine SCHEMBL6970249 0.81 CDK2 (0.70) CDK2EGFRPIK3CGJAK2PIK3CA
SCHEMBL6975909 0.81 JAK2 (0.70) CDK2EGFRPIK3CGJAK2PIK3CA
SCHEMBL7954409 0.81 CDK2 (0.73) CDK2EGFRPIK3CGJAK2PIK3CA
SCHEMBL25326552 0.81 SYK (0.63) CDK2EGFRPIK3CGJAK2PIK3CA
SCHEMBL4732945 0.80 PIK3CA (0.80) CDK2EGFRPIK3CGJAK2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009070328-A1 MODULATORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY FOR USE IN THE TREATMENT OR PREVENTION OF SUBSTANCE ABUSE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-06-04 WO disclosed
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 US disclosed
EP-0862560-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1998-09-09 EP disclosed
WO-1997019065-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1997-05-29 WO disclosed